AUS
NZ
UK
CA
USA
IND
Healthcare
The All Ordinaries Healthcare Share Price Under Discussion - SomnoMed
August 25, 2020 02:24 PM AEST| By Team Kalkine MediaSummary With a high prevalence that is expected to grow further, the obstructive sleep apnea (OSA) market is predicted to expand in the upcoming times. Sydney-headquartered SomnoMed Limited, engaged in developing devices for OSA treatment, repo.....
Imugene Receives Third Ethics Approval for PD1-Vaxx’s Phase 1 Trial in Australia
August 24, 2020 12:32 PM AEST| By Team Kalkine MediaThe stock of Australian clinical-stage immuno-oncology company, Imugene Limited (ASX:IMU) traded ~1.8 per cent higher on 21st August 2020 following the release of a significant update on PD1-Vaxx’s third ethics approval for Phase 1 trial. To.....
Needle on CardieX Limited: What's Driving the Impressive Stock Performance?
August 23, 2020 12:15 AM AEST| By Hina ChowdharyGlobal health technology company, CardieX Limited (ASX:CDX) has experienced a stupendous price rally with a six-month investor return of more than 107% and three-month investor return of 145.45%, as on 20 August 2020. The increase can be attributed.....
E-health Services - the Apparent Next Step Amid Digital Boom and Pandemic
August 22, 2020 01:28 AM AEST| By Team Kalkine MediaSummary Australian government intends to develop a national approach for digital health; however, challenges are hampering the pace of development. MedAdvisor reported a record revenue during Q4, up 41 per cent year-on-year, while FY20 reve.....
2 Healthcare Stocks to Watch Today: Healius, Mayne Pharma
August 21, 2020 08:55 PM AEST| By Team Kalkine MediaSummary Healius reported FY20 results which were in line with the guidance provided. Underlying EBIT and underlying NPAT were A$102.7 million and A$55.4 million, respectively. Resilience in Healius’ Pathology division continued into July .....
One Mid-cap All Ordinaries Healthcare Player that Investors Like: EBOS Share Price
August 21, 2020 05:08 PM AEST| By Team Kalkine MediaSummary Marketer and distributor of healthcare products, EBOS Group, witnessed strong performances from both Healthcare and Animal Care segments in FY20; total revenue grew by 26.5%. With the distribution of healthcare products falling under es.....
Is this ASX 200 Healthcare Player Still a Buy Post a Bullish Run? Sonic Healthcare
August 20, 2020 06:15 PM AEST| By Team Kalkine MediaThe share price of healthcare companies is on a watch as they announce impressive full-year results during the current reporting season. Many ASX 200 healthcare players have updated impressive FY20 results despite the challenging condition posed by.....
Next move on Vaccine: Government's agreement with AstraZeneca catering 25 million Australians
August 20, 2020 04:47 PM AEST| By Team Kalkine MediaRecently, Australia undertook strides to secure access to a promising vaccine in a move to diminish coronavirus pandemic and would offer free access to the vaccine for Australians. Scott Morrison Government has signed a landmark agreement with UK-.....
Popular Healthcare ASX Share Prices: CSL, Medical Developments
August 19, 2020 06:16 PM AEST| By Team Kalkine MediaSummary CSL Limited reported an NPAT of ~US$2,103 million for FY20, up 17% on a constant currency basis. The total full-year dividend rose to US$2.02 per share. CSL’s FY21 NPAT is expected to be in the range US$2,100-US$2,265 million at c.....
Is CSL share price still a buy this year?
August 19, 2020 04:01 PM AEST| By Team Kalkine MediaSummary Biotech player CSL Limited announced its FY20 results with an impressive growth of 17% and 9% in net profit after tax and revenue, respectively (on constant currency basis). CSL had earlier announced the initiation of first human trials.....
Healthcare Dynasty with Fisher & Paykel Share Price & Cochlear Post Profit/Loss Reporting
August 19, 2020 12:15 AM AEST| By Kunal SawhneySummary Hospital hardware sales of Fisher & Paykel have continued to steadily increase over the first four months of FY21 with over 390% cc revenue growth to the end of July compared to pcp. Fisher & Paykel disclosed that, at current ex.....
Latest updates in healthcare space: Lens on EMD and AT1
August 16, 2020 12:34 AM AEST| By Kunal SawhneySince the onset of a pandemic, the health system of Australia has experienced both challenges and opportunities as a result of COVID-19. Many companies are involved in preparing a vaccine for the global pandemic, and some are in various stages of c.....
COVID-19: A Catastrophe For Most But A Boon For Some; Biotech Players Relishing The Boom
August 16, 2020 12:32 AM AEST| By Team Kalkine MediaSummary Covid-19 pandemic appears to boost the market opportunity for biotech companies, mainly involved in the development of COVID-19 related tests kits, drugs, or vaccines. Increase in the testing burden with economic reopening is anti.....
Only ASX-listed Healthcare Company Developing CAR-T Programs- PTX Collaborates With Peter MacCallum Cancer Centre
August 14, 2020 08:58 PM AEST| By Team Kalkine MediaSummary Prescient collaborating with the world-class cell therapy institute Peter MacCallum Cancer Centre to develop innovative cell therapy technologies, including CAR-T technologies. Prescient will own the resulting IP from the research progr.....
Mesoblast Share Price Goes Berserk: Investors had a Sunny Day
August 14, 2020 07:17 PM AEST| By Team Kalkine MediaSummary Mesoblast disclosed the ODAC of the US FDA voted overwhelmingly in favour that the available data support the efficacy of remestemcel-L. Following the announcement, MSB’s share price zoomed and ended the trading session over 39% h.....
Why Healthcare Stocks Seem to be Losing Some Fizz - A Glance at Pharmaxis
August 13, 2020 06:59 PM AEST| By Team Kalkine MediaHealthcare sector of Australia offers several services and products through its constituent companies, such as healthcare services providers, medical device companies, along with biotechnology & pharma players, among others. Healthcare ser.....
Prescient Therapeutics’ PTX100 Phase 1b Basket Study Progressing Well, Moves to Next Dose Level
August 13, 2020 12:27 PM AEST| By Team Kalkine MediaSummary After demonstrating the safety at a dose of 1,000 mg/m2, Phase 1b study of PTX-100 will proceed to the increased dose of 2,000 mg/m2. Two patients from the first 500 mg/m2 cohort had reported with stable disease or better at the end of .....
Investors Smile with ASX-listed 1300 Smiles’ Stock Price Momentum
August 11, 2020 05:45 PM AEST| By Kunal SawhneyThe growing number of COVID-19 cases have led to several businesses going bankrupt with forced to ask their employees to work from home amid the pandemic-induced precautionary measures taken to curb the rapid spread of the virus. The impact of COVI.....
.jpg)
COVID-19 Vaccine Race Continuing at War Time Speed, Who will Pull Off?
August 11, 2020 04:39 PM AEST| By Team Kalkine MediaSummary Healthcare and pharma companies across the globe are burning their midnight oil to find a safe and effective vaccine against the coronavirus. While AstraZeneca is leading the race in terms of COVID-19 vaccine development, Moderna is not.....
Small Cap Healthcare Stock on A Tear as two leading candidates are tested against SARS-CoV-2
August 07, 2020 10:59 PM AEST| By Team Kalkine MediaA small cap healthcare company, whose stock has zoomed up 7x since the March lows, has embarked upon the race to undertake initial study of its drug candidates RECCE® 327 and RECCE® 529. The company’s two leading candidates are being te...
Advertise your brand on Kalkine Media